Ali Faraz
Tenaya Therapeutics, Inc. · Chief Executive Officer
Ali Faraz is listed in filings as Chief Executive Officer at Tenaya Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Tenaya Therapeutics, Inc. (TNYA). The current snapshot covers public activity from Aug 16, 2024 to May 19, 2026. Reported amounts are shown as $2.7K to $3.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3.8k5.9k shares | SellFeb 17, 2026 | $0.643 | $0.8035 | |
| $3.2k5k shares | SellFeb 17, 2026 | $0.643 | $0.8035 | |
| $2.6k4k shares | SellFeb 17, 2026 | $0.6431 | $0.8035 | |
| $4.2k3.1k shares | SellNov 17, 2025 | $1.33 | $0.8035 | |
| $4.9k3.9k shares | SellAug 18, 2025 | $1.25 | $0.8035 | |
| $7.2k5.7k shares | SellAug 18, 2025 | $1.25 | $0.8035 | |
| $6.2k4.9k shares | SellAug 18, 2025 | $1.25 | $0.8035 | |
| $1.4k3.2k shares | SellMay 16, 2025 | $0.4427 | $0.8035 | |
| $3.1k5.8k shares | SellMar 10, 2025 | $0.5384 | $0.8035 | |
| $2.1k3.9k shares | SellMar 10, 2025 | $0.5384 | $0.8035 | |
| $17k5.8k shares | SellAug 16, 2024 | $2.89 | $0.8035 | |
| $11k3.9k shares | SellAug 16, 2024 | $2.89 | $0.8035 |